Favipiravir is an anti-viral drug which is currently being tested in 18 clinical trials for COVID-19 Drugs and results from two studies have shown a...
Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate COVID-19 cases after it received the Indian drug regulator’s approval. It will be...
Subscribe To Our WhatsApp Group For Latest News Directly To Your Mobile